Cited by 111Systemic Lupus Erythematosus ResearchAcute Ischemic Stroke ManagementCerebral Venous Sinus Thrombosis

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Cerebrovascular Ischemic Events With High Positive Anticardiolipin Antibodies

Verro, Piero, Levine, Steven R., Tietjen, Gretchen E.·1998·Stroke

Open this paper in CoChat — free account

Abstract

Background and purpose The aim of our study was to characterize the patient profile and prognostic value associated with high positive IgG (>100 GPL) anticardiolipin antibodies (aCL). Methods We studied the clinical, laboratory, radiological, and prospective historical features of ischemic cerebrovascular disease in patients with >100 GPL titers. From our neurology department, 27 consecutive patients were prospectively identified and followed up (mean follow-up time, 34 months). Results The mean age of our cohort was 41 years. Lupuslike illness occurred in 3; 23 had primary antiphospholipid syndrome, including 3 who met criteria for Sneddon's syndrome; 1 patient had progressive systemic sclerosis. Cerebral infarcts occurred in 74% and were recurrent in 37%. Systemic ischemic events, most commonly deep vein thrombosis, occurred in 37%. Tobacco use was documented in 85%, hyperlipidemia in 74%, hypertension in 44%, and diabetes mellitus in 7% of patients. A prominent headache history was present in 67%. Lupus anticoagulant (LA) was present in 72%, approximately one half had positive antinuclear antibodies and thrombocytopenia, and one quarter had a false-positive VDRL. We compared mean GPL levels in patients testing positive for specific laboratory features of antiphospholipid syndrome with those testing negative for these parameters. Only the LA(+) group had a significantly higher mean GPL than the LA(-) group (P=0.006). Brain imaging showed nonlacunar infarcts in 73% and lacun…

Integrity signals

Registry

Crossref · 10.1161/01.str.29.11.2245

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Anti-phospholipid Antibodies
Harris, E. N., Gharavi, A. E., & Hughes, G. R. V. (1985) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00606-8 · Cited by 442
The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Anti-Phospholipid Antibody Study (KAPS) Group
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 413
ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS
Hamsten, A., Björkholm, M., Norberg, R., Fairé, U. D., & Holm, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92258-0 · Cited by 356
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome
Asherson, R. A., Khamashta, M. A., Gil, A., Vázquez, J. P. F., Chan, O., Baguley, E., & Hughes, G. R. V. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90335-5 · Cited by 328

Show all 51 references

Research works printed but not linked: 8

10.1161/str.21.9.2396261 · DOI
10.1161/str.29.9.1755 · DOI
Spinazzi A Noseda A Paloscia L Caputo M Maselli A Bonomo L. Association of levels of anticardiolipin (aCL) antibodies with peripheral atherosclerotic disease (PAD) documented by angiography. In: Proceedings of the Fifth International Symposium on Antiphospholipid Antibodies; September 9–12 1992; San Antonio Tex.
10.1161/str.19.5.3363593 · DOI
10.1161/str.23.2.1561646 · DOI
10.1161/str.22.6.2057974 · DOI
Turhim S, Rand JH, Goldbold JH, Weinberger J, Horowitz DR, Goldman M. Elevated antiphosphatidyl serine antibodies are a risk factor for ischemic stroke. Neurology. 1998;50:A246. Abstract.
10.1161/str.29.9.1759 · DOI

Sorted by citations

EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,318
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
Erkan, D. (2002) · Rheumatology · doi:10.1093/rheumatology/41.8.924 · Cited by 330
IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death
Levine, S. R., Salowich‐Palm, L., Sawaya, K. L., Perry, M., Spencer, H. J., Winkler, H. J., Alam, Z., & Carey, J. L. (1997) · Stroke · doi:10.1161/01.str.28.9.1660 · Cited by 212
Self-citation
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
Cohen, H., Cuadrado, M. J., Erkan, D., Duarte‐García, A., Isenberg, D. A., Knight, J. S., Ortel, T. L., Rahman, A., Salmon, J. E., Tektonidou, M. G., et al. (2020) · Lupus · doi:10.1177/0961203320950461 · Cited by 170
Risk Factors for Arterial Ischemic Stroke in Children
Kirkham, F. J., Prengler, M., Hewes, D. K. M., & Ganesan, V. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500506 · Cited by 127
Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andréoli, L., Limper, M., Tincani, A., & Ward, M. M. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000924 · Cited by 101
Primary Anti-Phospholipid Antibody Syndrome (APS)
Durrani, O. M., Gordon, C., & Murray, P. I. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00289-8 · Cited by 90
Anticardiolipin Antibodies Are Not an Independent Risk Factor for Stroke
Ahmed, E., Stegmayr, B., Trifunovic, J., Weinehall, L., Hallmans, G., & Lefvert, A. K. (2000) · Stroke · doi:10.1161/01.str.31.6.1289 · Cited by 88
CNS dysfunction in the antiphospholipid syndrome
Katzav, A., Chapman, J., & Shoenfeld, Y. (2003) · Lupus · doi:10.1191/0961203303lu500oa · Cited by 87
Neurological involvement in patients with rheumatic disease
Sofat, N., Malik, O., & Higgens, C. S. (2006) · QJM · doi:10.1093/qjmed/hcl005 · Cited by 83
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002
Brey, R. L., Chapman, J., Levine, S. R., Ruiz‐Irastorza, G., Derksen, R. H. W. M., Khamashta, M. A., & Shoenfeld, Y. (2003) · Lupus · doi:10.1191/0961203303lu390oa · Cited by 82
Self-citation
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children
Lanthier, S., Kirkham, F. J., Mitchell, L. G., Laxer, R. M., Atenafu, E. G., Male, C., Prengler, M., Domi, T., Chan, A. K. C., Liesner, R. J., et al. (2004) · Neurology · doi:10.1212/wnl.62.2.194 · Cited by 66
Antiphospholipid antibodies and thrombosis: strength of association
Galli, M., & Barbui, T. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200206 · Cited by 61
Risk factors for arterial thrombosis in antiphospholipid syndrome
Matyja‐Bednarczyk, A., Swadźba, J., Iwaniec, T., Sanak, M., Dziedzina, S., Ćmiel, A., & Musiał, J. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.11.012 · Cited by 54
MANAGEMENT OF THROMBOSIS IN ANTIPHOSPHOLIPID ANTIBODY SYNDROME
Petri, M. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70225-8 · Cited by 51
Antiphospholipid Syndrome
Keswani, S. C., & Chauhan, N. (2002) · Journal of the Royal Society of Medicine · doi:10.1177/014107680209500705 · Cited by 48
Factors Determining Headache at Onset of Acute Ischemic Stroke
Mitsias, P., Ramadan, N. M., Levine, S., Schultz, L., & Welch, K. M. A. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.01012.x · Cited by 46
Self-citation
Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome
de Souza, A. W. S., Silva, N. P., de Carvalho, J. F., D’Almeida, V., Noguti, M. A. E., & Sato, E. I. (2007) · Lupus · doi:10.1177/0961203307081847 · Cited by 43
Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
van Goor, M. P. J., Alblas, C. L., Leebeek, F. W. G., Koudstaal, P. J., & Dippel, D. W. J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00241.x · Cited by 42
Antiphospholipid syndrome, antiphospholipid antibodies, and stroke
Mittal, P., Quattrocchi, G., Tohidi‐Esfahani, I., Sayar, Z., Chandratheva, A., & Cohen, H. (2022) · International Journal of Stroke · doi:10.1177/17474930221150349 · Cited by 41
Antibodies to tissue‐type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
Cugno, M., Domínguez, M., Cabibbe, M., Bisiani, G., Galli, M., Anglés‐Cano, E., & Agostoni, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01948.x · Cited by 39
Neurologic manifestations of the antiphospholipid syndrome
Tanné, D., & Hassin‐Baer, S. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0032-3 · Cited by 38
Lupus anticoagulants and anti‐phospholipid antibodies as risk factors for a first episode of ischemic stroke
SAIDI, S., MAHJOUB, T., & ALMAWI, W. Y. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03446.x · Cited by 37
Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus
Morelli, S., Bernardo, M. L., Viganego, F., Sgreccia, A., Marzio, P. D., Conti, F., Priori, R., & Valesini, G. (2003) · Lupus · doi:10.1191/0961203303lu468oa · Cited by 36
Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review
Man, Y. L., & Sanna, G. (2022) · Brain Sciences · doi:10.3390/brainsci12010091 · Cited by 34
Differential Diagnosis of Central Nervous System Manifestations of the Antiphospholipid Antibody Syndrome
Brey, R. L. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0426 · Cited by 34
The Antiphospholipid Syndrome
D’Cruz, D. P., & Khamashta, M. A. (2009) · Springer eBooks · doi:10.1007/978-1-84800-934-9_16 · Cited by 31
Stroke and antiphospholipid syndrome: the treatment debate
Ruiz‐Irastorza, G., & Khamashta, M. A. (2005) · Rheumatology · doi:10.1093/rheumatology/keh666 · Cited by 30
The impact of gender on clinical manifestations of primary antiphospholipid syndrome
Jara, L. J., Medina, G., Lastra, O. L. V., & Barile, L. (2005) · Lupus · doi:10.1191/0961203305lu2176oa · Cited by 29
IgG and IgM isotypes of anti-cardiolipin and anti-β 2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events
Locht, H., & Wiik, A. S. (2005) · Clinical Rheumatology · doi:10.1007/s10067-005-1166-x · Cited by 29
Hughes syndrome crosses boundaries
Ruiz‐Irastorza, G., Khamashta, M. A., & Hughes, G. R. V. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(01)00005-2 · Cited by 28
RETRACTED: Evaluation of Antiphospholipid Antibodies in Youths Suffering from Cerebral Ischemia
Goldust, M., Talebi, M., Majidi, J., Saatlou, M. A. R., & Rezaee, E. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.749256 · Cited by 26
Retracted
Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease
Gonzales‐Portillo, F., McIntyre, J. A., Wagenknecht, D. R., Williams, L. S., Bruno, A., & Biller, J. (2001) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2001.29818 · Cited by 26
Smoking and inflammatory diseases
Vittecoq, O., Lequerré, T., Goëb, V., Loët, X. L., Aït-Abdesselam, T., & Klemmer, N. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.09.011 · Cited by 26
Serum lipids and anti-oxidized LDL antibodies in primary antiphospholipid syndrome.
Bećarević, M. B., Andrejević, S., Miljić, P., Bonaci-Nikolić, B., & Majkić‐Singh, N. (2007) · PubMed · Cited by 24
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
Naranjo, L., Ostos, F., Gil‐Etayo, F. J., Hernández‐Gallego, J., Cabrera-Marante, Ó., Pleguezuelo, D. E., Díaz‐Simón, R., Cerro, M., Lora, D., Martínez‐Salio, A., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.665741 · Cited by 23
Surgical treatment for encapsulating peritoneal sclerosis.
Kawanishi, H. (2002) · PubMed · Cited by 23
Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
Fonseca, A. G., & D’Cruz, D. P. (2008) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-5-6 · Cited by 23
Neurological and Neuroendocrine‐Cytokine Inter‐relationship in the Antiphospholipid Syndrome
Chapman, J., & Shoenfeld, Y. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04242.x · Cited by 21
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis
Aibar, J., & Schulman, S. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1725057 · Cited by 22
Anti-phospholipid Antibodies and Smoking: An Overview
Binder, S. R., & Litwin, C. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8565-4 · Cited by 21
Do we Know which Patients with the Antiphospholipid Syndrome Should Receive Long-term High Dose Anti-coagulation?
Derksen, R. H. W. M., & de Groot, P. G. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0395 · Cited by 19
Coagulation abnormalities and their neuro-ophthalmologic manifestations
Biousse, V. R. (1999) · Current Opinion in Ophthalmology · doi:10.1097/00055735-199912000-00004 · Cited by 18
Antiphospholipid Syndrome With Catastrophic Bleeding and Recurrent Ischemic Strokes as Initial Presentation of Systemic Lupus Erythematosus
Rodriguez, V., Reed, A. M., Kuntz, N. L., Anderson, P. M., Smithson, W. A., & Nichols, W. L. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000174565.91343.43 · Cited by 17
DIAGNOSTIC EVALUATION OF STROKE
Wityk, R. J., & Beauchamp, N. J. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70197-3 · Cited by 17
Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome
Rodríguez-Sanz, A., Martínez‐Sánchez, P., Prefasi, D., Fuentes, B., Pascual‐Salcedo, D., Blanco-Bañares, M. J., & Díez‐Tejedor, E. (2014) · Autoimmunity · doi:10.3109/08916934.2014.988329 · Cited by 16
Acquired thrombophilic syndromes
Matei, D. E., Brenner, B., & Marder, V. J. (2001) · Blood Reviews · doi:10.1054/blre.2001.0148 · Cited by 16
Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients
Li, C., Zuo, Y., Zhang, S., Makris, U. E., Karp, D. R., & Li, Z. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001964 · Cited by 16
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome
Cohen, H., Sayar, Z., Efthymiou, M., Gaspar, P., Richards, T., & Isenberg, D. A. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30116-2 · Cited by 17
High Titer of Anticardiolipin Antibody Is Associated with First-Ever Ischemic Stroke in Taiwan
Lien, L., Chen, W., Chiu, H., Pan, W., Chen, J.-R., & Bai, C. (2006) · Cerebrovascular Diseases · doi:10.1159/000094008 · Cited by 14
Novel Insights Into Associations of Antibodies Against Cardiolipin and beta2-glycoprotein I with Clinical Features of Antiphospholipid Syndrome
Shovman, O., Gilburd, B., Barzilai, O., Langevitz, P., & Shoenfeld, Y. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-0001-3 · Cited by 13
Antithrombotic therapy in antiphospholipid syndrome with arterial thrombosis: a systematic review and network meta-analysis
Attachaipanich, T., Aungsusiripong, A., Piriyakhuntorn, P., Hantrakool, S., Rattarittamrong, E., Rattanathammethee, T., Tantiworawit, A., Norasetthada, L., & Chai‐Adisaksopha, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1196800 · Cited by 13
Severity and outcomes according to stroke etiology in patients under 50 years of age with ischemic stroke
Prefasi, D., Martínez‐Sánchez, P., Fuentes, B., & Díez‐Tejedor, E. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1336-5 · Cited by 12
Treatment of thrombotic antiphospholipid syndrome in adults and children
Madison, J. A., Duarte‐García, A., Zuo, Y., & Knight, J. S. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000702 · Cited by 12
Cardiopatía valvular en pacientes con síndrome antifosfolipídico
Muñoz, F. J., Reverter, J. C., Franco, J. F., Garriga, G. E., Tàssies, D., & Morin, M. (2002) · Revista Clínica Española · doi:10.1016/s0014-2565(02)71136-3 · Cited by 11
Coexistence of antiphospholipid antibodies and cephalalgia
Islam, M. A., Alam, F., Gan, S. H., Cavestro, C., & Wong, K. K. (2017) · Cephalalgia · doi:10.1177/0333102417694881 · Cited by 10
Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome
Liu, M., Li, G., Song, X., Fan, Y., & Li, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-35955-2 · Cited by 10
Cerebral Disease in the Antiphospholipid Syndrome
Navarrete, M. G., Brey, R. L., & Levine, S. R. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_5 · Cited by 9
Self-citation
Plasma antiphospholipid antibody levels in age-related macular degeneration
Özkan, B., Karabas, L. V., Altıntaş, Ö., Tamer, G. S., Yüksel, N., & Çağlar, Y. (2012) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2012.03.016 · Cited by 8
Neurologic Manifestations in the Antiphospholipid Syndrome
Brey, R. L., Levine, S. R., & Stallworth, C. L. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50019-x · Cited by 8
Self-citation
Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (hughes syndrome)
Cuadrado, M. J. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0083-0 · Cited by 8
Antiphospholipid Syndrome
Levine, S. R., & Erkan, D. (2004) · Technical report · doi:10.1016/s1571-5078(04)03004-1 · Cited by 8
Self-citation
Advances in the pharmacological management of systemic lupus erythematosus
Tsoi, A., Nikolopoulos, D., & Parodis, I. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2354457 · Cited by 10
Estrategias terapéuticas en el síndrome antifosfolipídico
Cervera, R. (2009) · Reumatología Clínica · doi:10.1016/j.reuma.2008.11.020 · Cited by 8
Lupus anticoagulants in children
Briones, M. A., & Abshire, T. C. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200309000-00009 · Cited by 7
In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome
Cockerill, K. A., Smith, E., Jones, D. S., Branks, M. J., Hayag, M. S., Victoria, E. J., Linnik, M. D., & Campbell, M.-A. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00203-0 · Cited by 7
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications
Bucci, T., Menichelli, D., Palumbo, I., Pastori, D., Ames, P. R. J., Lip, G. Y. H., & Pignatelli, P. (2025) · Cells · doi:10.3390/cells14050353 · Cited by 8
Therapeutic strategies in antiphospholipid syndrome
Cervera, R. (2010) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(10)70007-1 · Cited by 6
The Antiphospholipid Syndrome
D’Cruz, D. P., Knight, J. S., Sammaritano, L. R., Salmon, J. E., Cervera, R., & Khamashta, M. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_14 · Cited by 6
The interaction of persistent antiphospholipid antibodies positivity and cigarette smoking is associated with an increased risk of cardiovascular events: Cross-sectional and longitudinal analysis
Xu, J., Fan, Y., Zhou, R., Shao, J., Guo, H., Chen, Y., Wang, Q., Dong, Z., Li, M., Chen, Y., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.12.008 · Cited by 5
The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik, A., Kowal‐Bielecka, O., Domysławska, I., Chwiećko, J., & Sierakowski, S. (2005) · PubMed · Cited by 5
Coagulation Abnormalities in Stroke
Coull, B. M., & Drake, K. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10041-7 · Cited by 5
Induced Minor Malformations in the Neocortex of Normal Mice do not Alter Immunological Functions
Gogal, R. M., Ahmed, S. A., Holladay, S. D., Walsh, J. E., Galaburda, A. M., & Rosen, G. D. (2000) · Immunological Investigations · doi:10.3109/08820130009060869 · Cited by 5
Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children
Lewis, K., Tambralli, A., & Madison, J. A. (2025) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001083 · Cited by 7
Causal association between systemic lupus erythematosus and the risk of migraine: A Mendelian randomization study
Ren, M., Yu, H., Xiao, B., Zhao, Y., Yan, J., & Liu, J. X. (2024) · Brain and Behavior · doi:10.1002/brb3.3417 · Cited by 3
Antiphospholipid antibodies and stroke†
SHANAHAN, J., & Ortel, T. L. (2002) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2002.124067 · Cited by 4
Management of Thrombosis in Antiphospholipid Syndrome
Khamashta, M. A., & Ruiz‐Irastorza, G. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_43 · Cited by 4
Coagulation Abnormalities in Stroke
Brey, R. L., & Coull, B. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50040-7 · Cited by 4
Anti-phospholipid antibody syndrome
Roldan, J. F., & Brey, R. L. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.039 · Cited by 3
Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke
Yang, W., Chung, M. J., Ha, J., Kang, D., Lee, E., Jeong, H., Kim, J., Jung, K., & Lee, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-91739-w · Cited by 3
Evaluation of the Different Antiphospholipid Antibodies for the Diagnosis of Antiphospholipid Syndrome
Kaushik, P., MALAVIYA, A. N., Al-Attiya, R., Moussa, M. A. A., & Das, K. C. (1999) · Medical Principles and Practice · doi:10.1159/000026110 · Cited by 3
Ischemic and nonischemic manifestations of antiphospholipid syndrome
Tukhfatullina, S. I., & Gaynetdinova, D. D. (2015) · Kazan medical journal · doi:10.17750/kmj2015-061 · Cited by 3
Unusual Causes of Ischaemic Stroke and Transient Ischaemic Attack
Warlow, C., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Stroke · doi:10.1002/9780470696361.ch7 · Cited by 3
Antiphospholipid syndrome: treatment controversies
Ruiz‐Irastorza, G., & Khamashta, M. A. (2006) · Future Rheumatology · doi:10.2217/17460816.1.3.345 · Cited by 3
Accelerated Atherosclerosis in the Aortic Arch and Cerebral Ischemia in a Patient with Primary Antiphospholipid Syndrome
Pengo, V., Zocche, A., Scognamiglio, R., Biasiolo, A., Roš, T., & Ruffatti, A. (2001) · Elsevier eBooks · doi:10.1016/b978-044450669-6/50034-7 · Cited by 3
Tabac et maladies systémiques
Goëb, V., Klemmer, N., Loët, X. L., & Vittecoq, O. (2007) · Revue du Rhumatisme · doi:10.1016/j.rhum.2007.06.001 · Cited by 2
Recurrent strokes and memory loss in a patient with triple-positive antiphospholipid antibody syndrome
Osuorji, C., Bilal, J., & Osuorji, I. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-246104 · Cited by 2
Risk factors for cerebral infarction and cerebrovascular stenosis in antiphospholipid antibody-positive patients: A retrospective single-center study with propensity score matching analysis
Ha, S. H., Kim, S. U., Huh, J., & Huh, C.-W. (2024) · Medicine · doi:10.1097/md.0000000000039890 · Cited by 2
Nonatherosclerotic Vasculopathies
Caplan, L. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4721-6.50013-4 · Cited by 2
Neuroimaging of Cardiovascular Disease
Cohen, R. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_15 · Cited by 3
Accidente cerebrovascular agudo en el síndrome antifosfolipídico primario
Sabé, N., Palacı́n, A., Sampere, I. M., Perujo, E. S., de Evan, M. J., Borrego, F. R., & Farriols, R. P. (2002) · Revista Clínica Española · doi:10.1016/s0014-2565(02)71119-3 · Cited by 2
Coagulation Studies
Furie, K. L., Kelly, P. J., & Kistler, J. P. (2004) · doi:10.1002/9780470988442.ch9 · Cited by 2
Hematologic Disorders and Stroke
Bushnell, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00042-6 · Cited by 1
Síndrome de Hughes y trombosis: el debate continúa
Ruiz‐Irastorza, G., & Khamashta, M. A. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)72297-5 · Cited by 1
Occlusion du tronc artériel brachio-céphalique associée à un syndrome des antiphospholipides : traitement par angioplastie-stent
Dumurgier, J., Desgranges, P., Chapoy, E., Becquemin, J.-P., & Hosseini, H. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)71149-2 · Cited by 1
Anticuerpos antifosfolípidos en la isquemia cerebral
Luis, I. S., & Rodríguez, Y. R. (2002) · DOAJ (DOAJ: Directory of Open Access Journals)
Anticardiolipin antibodies as markers of physiologic stress: a case study of idiopathic stroke in a young adult
Segler, C. P. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.036
Tabac et maladies systémiques Tobacco and connective tissue diseases
Goëb, V., Klemmer, N., Loët, X. L., & Vittecoq, O. (2007)
Síndrome antifosfolípido primario infantil
Checa, M. B. B., Vázquez, M. L. B., Sánchez, C. E., Perez, J., & Santos, S. S. (2006) · Rehabilitación · doi:10.1016/s0048-7120(06)74854-x
The Immunologic Basis, Neurological Manifestations and Management of The Anti Phospholipid Antibody Syndrome
Raina, M. B., Deka, N., Tashigang, T. P., & Kohli, A. (2005) · Apollo Medicine · doi:10.1016/s0976-0016(12)60053-2

Authors: Verro, P., Levine, S. R., & Tietjen, G. E.
Affiliations: Henry Ford Health (US)
ORCID: Levine, Steven R.
Tietjen, Gretchen E.
Venue: Stroke
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1998-11
Volume: 29
Issue: 11
Pages: 2245-2253
ISSN: 0039-2499 (ISSN-L)
1524-4628
DOI: 10.1161/01.str.29.11.2245
OpenAlex: W2132099411
Cited by: 111
References: 51
Citations by year: 2025: 4 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 3 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
FWCI: 4.30
Type: journal article
Language: en
Open access: closed
Locations: Stroke (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Neurological Disorders and Stroke (NS-30896, R01NS030896, NS-23393)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords: anticardiolipin antibodies, antiphospholipid syndrome, lupus anticoagulant, cerebral ischemia, cerebral infarction, recurrent ischemic events, deep vein thrombosis, prognosis, IgG antibody titers, neurological deficit, thrombocytopenia, antinuclear antibodies, VDRL test
MeSH terms: Adult, Aged, Intracranial Embolism and Thrombosis, Ischemic Attack, Transient, Cerebrovascular Disorders, Disability Evaluation, Echocardiography, Follow-Up Studies, Humans, Immunoglobulin G, Magnetic Resonance Imaging, Middle Aged, Prospective Studies, Risk Factors, Tomography, X-Ray Computed, Lupus Coagulation Inhibitor, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cerebrovascular Ischemic Events With High Positive Anticardiolipin Antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks